Biological E begins phase I, II human trials of Covid vaccine Ruchika Sharma17 Nov 2020 1:55 PM ISTHyderabad: Biological E. Limited, a Hyderabad-based vaccines and pharmaceutical company, Dynavax Technologies Corporation , a US-based vaccine focused...
Phase-1 human trials of antisera with potential COVID-19 treatment gets DCGI okay Ruchika Sharma7 Oct 2020 12:45 PM IST"The ICMR and Biological E Limited, Hyderabad, have developed highly purified antisera(raised in animals) for prophylaxis and treatment of COVID-19,"...
Biological E, ICMR to develop COVID treatment by injecting inactivated SARS-CoV2 in horses Ruchika Sharma3 Oct 2020 2:01 PM ISTThe 'antisera' is yet to undergo human clinical trials to establish its safety and efficacy and the Drugs Controller General of India (DCGI) would be...
Biological E, Baylor College of Medicine enter licensing agreement for affordable COVID vaccine Farhat Nasim29 Aug 2020 12:43 PM ISTHouston: In the race to find a cure for the coronavirus infection, Texas-based Baylor College of Medicine (BCM) has entered into a licensing agreement...
Govt panel meets COVID vaccine makers including Serum Institute, Zydus Cadila, others Ruchika Sharma18 Aug 2020 1:00 PM ISTNew Delhi: The national expert group on vaccine administration for Covid-19 met representatives of leading domestic manufactures, including Serum...
Biological E acquires Akorn injectable plant in India Ruchika Sharma18 Aug 2020 12:32 PM ISTBE is in the process of developing a COVID-19 vaccine and may be able to use the facilities at Akorn India Paonta Sahib Plant in Himachal pradesh for...
